1. Home
  2. AUPH vs SERV Comparison

AUPH vs SERV Comparison

Compare AUPH & SERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SERV
  • Stock Information
  • Founded
  • AUPH 1993
  • SERV 2017
  • Country
  • AUPH Canada
  • SERV United States
  • Employees
  • AUPH N/A
  • SERV N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SERV Industrial Specialties
  • Sector
  • AUPH Health Care
  • SERV Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • SERV Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SERV 964.9M
  • IPO Year
  • AUPH 1999
  • SERV N/A
  • Fundamental
  • Price
  • AUPH $7.93
  • SERV $12.01
  • Analyst Decision
  • AUPH Strong Buy
  • SERV Strong Buy
  • Analyst Count
  • AUPH 3
  • SERV 3
  • Target Price
  • AUPH $10.33
  • SERV $17.00
  • AVG Volume (30 Days)
  • AUPH 1.0M
  • SERV 13.1M
  • Earning Date
  • AUPH 02-27-2025
  • SERV 03-06-2025
  • Dividend Yield
  • AUPH N/A
  • SERV N/A
  • EPS Growth
  • AUPH N/A
  • SERV N/A
  • EPS
  • AUPH N/A
  • SERV N/A
  • Revenue
  • AUPH $220,361,000.00
  • SERV $1,679,360.00
  • Revenue This Year
  • AUPH $36.97
  • SERV $831.36
  • Revenue Next Year
  • AUPH $16.43
  • SERV $602.38
  • P/E Ratio
  • AUPH N/A
  • SERV N/A
  • Revenue Growth
  • AUPH 38.72
  • SERV 692.32
  • 52 Week Low
  • AUPH $4.71
  • SERV $1.77
  • 52 Week High
  • AUPH $10.67
  • SERV $30.00
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 47.47
  • SERV N/A
  • Support Level
  • AUPH $7.50
  • SERV N/A
  • Resistance Level
  • AUPH $8.12
  • SERV N/A
  • Average True Range (ATR)
  • AUPH 0.27
  • SERV 0.00
  • MACD
  • AUPH 0.02
  • SERV 0.00
  • Stochastic Oscillator
  • AUPH 53.49
  • SERV 0.00

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About SERV Serve Robotics Inc. Common Stock

Serve Robotics Inc is developing next-generation robots for last-mile delivery services. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an advanced, AI-robotics mobility platform, with last-mile delivery in cities as its first application.

Share on Social Networks: